Does BELANTAMAB MAFODOTIN Cause Thrombocytopenia? 90 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Thrombocytopenia have been filed in association with BELANTAMAB MAFODOTIN (Blenrep). This represents 3.9% of all adverse event reports for BELANTAMAB MAFODOTIN.
90
Reports of Thrombocytopenia with BELANTAMAB MAFODOTIN
3.9%
of all BELANTAMAB MAFODOTIN reports
39
Deaths
35
Hospitalizations
How Dangerous Is Thrombocytopenia From BELANTAMAB MAFODOTIN?
Of the 90 reports, 39 (43.3%) resulted in death, 35 (38.9%) required hospitalization, and 15 (16.7%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for BELANTAMAB MAFODOTIN.
What Other Side Effects Does BELANTAMAB MAFODOTIN Cause?
Keratopathy (788)
Visual acuity reduced (708)
Death (499)
Plasma cell myeloma (380)
Dry eye (359)
Night blindness (317)
Photophobia (183)
Foreign body sensation in eyes (151)
Vision blurred (134)
Ocular toxicity (94)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which BELANTAMAB MAFODOTIN Alternatives Have Lower Thrombocytopenia Risk?
BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF
BELANTAMAB MAFODOTIN vs BELATACEPT
BELANTAMAB MAFODOTIN vs BELIMUMAB
BELANTAMAB MAFODOTIN vs BELINOSTAT
BELANTAMAB MAFODOTIN vs BELUMOSUDIL